Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Mammography equipment is a type of medical imaging equipment that uses X-rays to capture images (mammograms) of the internal structures of the breasts. GlobalData uses proprietary data and analytics to provide a comprehensive report on the mammography equipment devices market, including market shares of different players within Taiwan. Buy the latest report here.
In 2021, GlobalData’s Market Model methodology determined that the leading player in the mammography equipment market in Taiwan was Hologic followed by GE Healthcare, Fujifilm, Siemens Healthineers and Philips Healthcare.
Mammography plays a key role in early diagnosis of breast cancer. 2D digital mammography equipment, breast tomosynthesis and retrofit breast tomosynthesis are covered in this category. Tracked here are the equipment only and not accessories and/or additional costs associated with mammography equipment installation. In 2D Digital Mammography Equipment, X-ray beams are captured on the digital camera and images are produced by the computer, and that images are sent electronically to the radiologists to view. Breast tomosynthesis is a system in which the imaging machines moves around the breast in an arc and taking multiple X-rays that is converted by the computer into 3D images. Retrofit breast tomosynthesis systems are digital panel detectors that enable the upgrade of 2D Digital Mammography Equipment to 3D Digital Mammography Equipment by retrofitting rotating gantry DBT (Digital Breast Tomosynthesis) scanner with a spatially distributed CNT (Carbon Nanotube) X-ray source array.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the mammography equipment devices market within Taiwan was expected to be over $5m in 2021.
For the latest complete market share analysis of mammography equipment device market in Taiwan, buy the report here.